Global healthcare company, Abbott, announced that its continuous glucose monitoring system Lingo can now be purchased in the U.S. without a prescription.
Lingo contains a biosensor and mobile app that is based on Abbott's FreeStyle Libre continuous glucose monitoring technology.
The system is a bio wearable product intended for people older than 18 years who are not taking insulin.
It tracks...
E-pharmacy MrMed scores half mil for expansion
Online pharmacy MrMed has raised $500,000 from a funding round led by the Tamil Nadu Emerging Sector Seed Fund.
According to a news report, the company will use its fresh funds to expand its team and reach out to more customers.
Launched in 2021, the pharmacy startup offers specialty medicines for cancer, heart disorders, and other critical health...
ORLANDO, Fla. – While technology continues to propel clinical trials, research in the U.S. still lacks accurate representation of the country.
"What we know is that race and ethnicity are social constructs and are not dependent on our genes," Jennifer Jones-McMeans, divisional vice president of global clinical affairs for Abbott’s vascular business, said during a HIMSS22 session. "When we look...
Abbott's implantable cardiac sensor system CardioMEMS landed an expanded FDA clearance, allowing earlier stage heart failure patients to use the tech.
The system, which is designed to monitor pressure changes in the heart, is implanted in a patient's pulmonary artery during a minimally invasive procedure. The connected sensor is able to send data daily to doctors and care teams about a patient's...
Taiwan-based diabetes management app Health2Sync has launched the latest version of its mobile app for about 200,000 users in Japan that now integrates continuous glucose monitoring data from the Abbott FreeStyle LibreLink mobile app.
WHY IT MATTERS
This data integration, said Health2Sync in a statement, will enable comprehensive health management for people with diabetes. It will allow them to...
Abbott landed FDA clearance for its imaging software, which employs artificial intelligence to give doctors a clearer look at blood flow and blockages in heart vessels.
The Ultreon 1.0 Software pairs optical coherence tomography with AI to help physicians make decisions about next steps for treatment.
"As cardiologists continue to adopt OCT and move away from traditional imaging methods such as...
06:05 am
June 11, 2021
Dr Cadamuro conducted a review to discover the underlying cost of microcytic anaemia. He looked back over Microcytic cases to find out where errors occurred in the diagnostic process using Abbott’s AlinIQ Clinical Decision Support. The next step is validating the clinical algorithm and rules to work with, using AlinIQ Clinical Decision Support solution, articulating an adequate follow up of the ...
Abbott announced today that it has updated NeuroSphere, its app-driven neuromodulation therapy platform, with remote programming capabilities that will allow patients to speak with and receive adjustments from their provider via a cellular or WiFi connection.
The NeuroSphere Virtual Clinic was recently approved by the FDA and is now available within the Abbott patient controller app for use with...
Walgreens has tapped some of the biggest names in digital health like Abbott, BetterHelp and Hinge Health to expand its offering on its Find Care platform.
The pharmacy retail giant has now included 11 new digital health companies in the Find Care platform, which was first launched in 2018 to help connect customers to healthcare providers. As of today, a total of 45 digital health companies are...
Abbott landed an emergency use authorization (EUA) for a new at-home coronavirus antigen test where users can perform the test on themselves via digital guidance and get results in 20 minutes. The test, priced at $25, is prescription based.
This isn't the first EUA for the testing product, known as BinaxNOW. However, the tool's first authorization designated that medical personnel conduct the...
